Melanoma addiction to GCDH defines NRF2 tumor suppressor function, November 18, 21

Melanoma addiction to GCDH defines NRF2 tumor suppressor functionProf. Ze’ev Ronai Director, NCI designated Cancer CenterSanford-Burnham-PrebysMedical Discovery Institute18 November 2021 Tumor dependency on specific metabolic signals has guided numerous therapeuticapproaches. Here we identify melanoma addiction to the lysine metabolism pathway,which… Continue Reading